4//SEC Filing
MUNDKUR CHRISTINE 4
Accession 0001209191-08-067579
CIK 0000010081other
Filed
Dec 28, 7:00 PM ET
Accepted
Dec 29, 5:43 PM ET
Size
25.5 KB
Accession
0001209191-08-067579
Insider Transaction Report
Form 4
MUNDKUR CHRISTINE
Sr.VP, Quality and Reg Counsel
Transactions
- Disposition to Issuer
Stock Appreciation Rights
2008-12-23−27,872→ 0 totalExercise: $46.99Exp: 2015-07-27→ Common Stock (27,872 underlying) - Disposition to Issuer
Stock Appreciation Rights
2008-12-23−30,000→ 0 totalExercise: $48.80From: 2008-11-11Exp: 2016-07-26→ Common Stock (30,000 underlying) - Disposition to Issuer
Common Stock
2008-12-23−5,406→ 0 total - Disposition to Issuer
Stock Options
2008-12-23−42,690→ 0 totalExercise: $43.34Exp: 2013-07-30→ Common Stock (42,690 underlying) - Disposition to Issuer
Stock Options
2008-12-23−27,144→ 0 totalExercise: $35.01Exp: 2014-08-04→ Common Stock (27,144 underlying) - Disposition to Issuer
Stock Options
2008-12-23−42,721→ 0 totalExercise: $26.58Exp: 2012-08-07→ Common Stock (42,721 underlying) - Disposition to Issuer
Stock Appreciation Rights
2008-12-23−15,000→ 0 totalExercise: $49.49From: 2008-11-11Exp: 2017-03-07→ Common Stock (15,000 underlying) - Disposition to Issuer
Stock Appreciation Rights
2008-12-23−75,000→ 0 totalExercise: $49.22From: 2008-11-11Exp: 2018-03-04→ Common Stock (75,000 underlying)
Footnotes (10)
- [F1]Disposed of pursuant to a merger agreement between Issuer and Teva Pharmaceutical Industries Ltd. in exchange for 3391 shares of Teva Common Stock having a market value of $41.82 per share on the effective date of the merger and cash in the amount of $215,738.25.
- [F10]These options were cancelled pursuant to the merger agreement between the Issuer and Teva in exchange for the aggregate cash payment of $1,296,000, which represents the difference between the $66.50 per share price specified in the merger agreement and the option price of $49.22 per share.
- [F2]Option vested equally over a 3 year period from grant date
- [F3]These options were cancelled pursuant to the merger agreement between the Issuer and Teva in exchange for the aggregate cash payment of $1,705,422.32, which represents the difference between the $66.50 per share price specified in the merger agreement and the option price of $26.58 per share.
- [F4]These options were cancelled pursuant to the merger agreement between the Issuer and Teva in exchange for the aggregate cash payment of $988,700.40, which represents the difference between the $66.50 per share price specified in the merger agreement and the option price of $43.34 per share.
- [F5]These options were cancelled pursuant to the merger agreement between the Issuer and Teva in exchange for the aggregate cash payment of $854,764.56, which represents the difference between the $66.50 per share price specified in the merger agreement and the option price of $35.01 per share.
- [F6]These options were cancelled pursuant to the merger agreement between the Issuer and Teva in exchange for the aggregate cash payment of $543,782.72, which represents the difference between the $66.50 per share price specified in the merger agreement and the option price of $46.99 per share.
- [F7]These options were cancelled pursuant to the merger agreement between the Issuer and Teva in exchange for the aggregate cash payment of $531,000, which represents the difference between the $66.50 per share price specified in the merger agreement and the option price of $48.80 per share.
- [F8]These options were cancelled pursuant to the merger agreement between the Issuer and Teva in exchange for the aggregate cash payment of $255,155, which represents the difference between the $66.50 per share price specified in the merger agreement and the option price of $49.49 per share.
- [F9]These options were cancelled pursuant to the merger agreement between the Issuer and Teva in exchange for the aggregate cash payment of $320,700, which represents the difference between the $66.50 per share price specified in the merger agreement and the option price of $55.81 per share.
Documents
Issuer
BARR PHARMACEUTICALS INC
CIK 0000010081
Entity typeother
Related Parties
1- filerCIK 0001237264
Filing Metadata
- Form type
- 4
- Filed
- Dec 28, 7:00 PM ET
- Accepted
- Dec 29, 5:43 PM ET
- Size
- 25.5 KB